Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary toxicity of bleomycin.

I Y Adamson

    Environmental Health Perspectives
    |August 1, 1976
    PubMed
    Summary

    Bleomycin causes lung injury starting with endothelial damage, leading to fibrosis. Epithelial repair is altered, with type 2 cells dividing but not fully transforming, impacting lung recovery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Inhalation toxicology of urban ambient particulate matter: acute cardiovascular effects in rats.

    Research report (Health Effects Institute)·2002
    Same author

    KGF and HGF are growth factors for mesothelial cells in pleural lavage fluid after intratracheal asbestos.

    Experimental lung research·2001
    Same author

    Proliferation of rat pleural mesothelial cells in response to hepatocyte and keratinocyte growth factors.

    American journal of respiratory cell and molecular biology·2000
    Same author

    Zinc is the toxic factor in the lung response to an atmospheric particulate sample.

    Toxicology and applied pharmacology·2000
    Same author

    Relationship of keratinocyte growth factor and hepatocyte growth factor levels in rat lung lavage fluid to epithelial cell regeneration after bleomycin.

    The American journal of pathology·1999
    Same author

    Pulmonary toxicity of an atmospheric particulate sample is due to the soluble fraction.

    Toxicology and applied pharmacology·1999

    Area of Science:

    • Pulmonary Medicine
    • Toxicology
    • Cell Biology

    Background:

    • Diffuse pulmonary fibrosis is a serious side effect of bleomycin treatment in humans.
    • The precise cellular mechanisms underlying bleomycin-induced lung injury require further elucidation.

    Purpose of the Study:

    • To investigate the sequential cellular reactions in mouse lungs following bleomycin administration.
    • To identify the initial site of injury and critical events triggering fibrotic responses.

    Main Methods:

    • Mice were injected with bleomycin (20 mg/kg) twice weekly for 4 to 8 weeks.
    • Lung tissues were examined to observe cellular and structural changes over time.

    Main Results:

    • Bleomycin induced edema in pulmonary vessels, progressing to capillaries.
    • Endothelial lesions were followed by type 1 epithelial cell necrosis and intraalveolar fibrin deposition.
    • Fibroblastic organization of fibrin led to collagen deposition and septal fibrosis by 8 weeks.
    • Type 2 epithelial cells underwent division and metaplasia, retaining DNA synthesis capacity.

    Conclusions:

    • Pulmonary endothelium is the primary target of bleomycin injury.
    • Damage to endothelial cells facilitates bleomycin access to interstitial and epithelial compartments.
    • Type 1 epithelial necrosis is a key event initiating the fibrotic cascade.

    Related Experiment Videos